Adequate relief of IBS and change in pain scores ≥30 at week 12.
a. A greater proportion of subjects receiving pregabalin reported adequate relief of IBS compared to subjects receiving placebo (p>0.05)
b. A trend was seen where a greater percentage of the pregabalin treatment arm had at least a 30-point improvement in their abdominal pain scores compared with the placebo arm.
Not adjusted for age and gender